GR3007194T3 - - Google Patents

Info

Publication number
GR3007194T3
GR3007194T3 GR930400439T GR930400439T GR3007194T3 GR 3007194 T3 GR3007194 T3 GR 3007194T3 GR 930400439 T GR930400439 T GR 930400439T GR 930400439 T GR930400439 T GR 930400439T GR 3007194 T3 GR3007194 T3 GR 3007194T3
Authority
GR
Greece
Prior art keywords
urokinase
plasminogen
lys
pro
infusion
Prior art date
Application number
GR930400439T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007194T3 publication Critical patent/GR3007194T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR930400439T 1987-09-18 1993-03-02 GR3007194T3 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878721951A GB8721951D0 (en) 1987-09-18 1987-09-18 Organic compounds

Publications (1)

Publication Number Publication Date
GR3007194T3 true GR3007194T3 (OSRAM) 1993-07-30

Family

ID=10623981

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400439T GR3007194T3 (OSRAM) 1987-09-18 1993-03-02

Country Status (11)

Country Link
EP (1) EP0307847B1 (OSRAM)
JP (1) JP2820699B2 (OSRAM)
AT (1) ATE82860T1 (OSRAM)
AU (1) AU623347B2 (OSRAM)
CA (1) CA1337046C (OSRAM)
DE (1) DE3876348T2 (OSRAM)
DK (1) DK518788A (OSRAM)
ES (1) ES2053658T3 (OSRAM)
GB (1) GB8721951D0 (OSRAM)
GR (1) GR3007194T3 (OSRAM)
NZ (1) NZ226217A (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2764264B2 (ja) * 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
AT402263B (de) * 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
WO1994001128A1 (en) * 1992-07-01 1994-01-20 Beth Israel Hospital Boston Enhancement of thrombolytic therapy with deglycosylated plasminogen
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
US7202066B2 (en) 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
DK3391902T5 (da) * 2015-12-18 2024-09-23 Talengen Int Ltd Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati
CN106890318A (zh) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 一种预防和治疗糖尿病性心脏病的新方法
JP7213553B2 (ja) 2016-12-15 2023-01-27 タレンゲン インターナショナル リミテッド 肺の繊維化を予防及び治療するための方法
JP7175270B2 (ja) 2016-12-15 2022-11-18 タレンゲン インターナショナル リミテッド グルカゴン、インスリンを正常なバランスに戻らせる方法
US11207387B2 (en) 2016-12-15 2021-12-28 Talengen International Limited Method and drug for preventing and treating obesity
TW202123963A (zh) 2016-12-15 2021-07-01 大陸商深圳瑞健生命科學研究院有限公司 一種治療冠狀動脈粥樣硬化及其併發症的方法
WO2018107707A1 (zh) * 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种改善心脏病变的方法
JP7335609B2 (ja) 2017-06-19 2023-08-30 タレンゲン インターナショナル リミテッド Ｇｌｐ－１／ｇｌｐ－１ｒを調節制御する方法および薬剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504921A1 (fr) * 1981-04-30 1982-11-05 Choay Sa Medicament nouveau constitue par un complexe aprotinine-plasmine et procede de preparation de ce nouveau complexe
IL80166A0 (en) * 1985-10-01 1986-12-31 American Home Prod Method of enhancing t-pa and scu-pa production

Also Published As

Publication number Publication date
DE3876348T2 (de) 1993-06-09
GB8721951D0 (en) 1987-10-28
DK518788D0 (da) 1988-09-16
NZ226217A (en) 1991-07-26
EP0307847A3 (en) 1990-03-07
ATE82860T1 (de) 1992-12-15
JP2820699B2 (ja) 1998-11-05
DE3876348D1 (en) 1993-01-14
EP0307847B1 (en) 1992-12-02
DK518788A (da) 1989-03-19
AU2240088A (en) 1989-03-23
JPH0283335A (ja) 1990-03-23
AU623347B2 (en) 1992-05-14
EP0307847A2 (en) 1989-03-22
ES2053658T3 (es) 1994-08-01
CA1337046C (en) 1995-09-19

Similar Documents

Publication Publication Date Title
GR3007194T3 (OSRAM)
OA08940A (en) Single-use, self-annulling injection syringe.
DE3873712D1 (de) Zusammensetzung mit einem biologisch abbaubaren augenimplantat.
AU1250588A (en) Syringe hypodermic needle
FI894361A7 (fi) Injektori lääkerakeiden ihonalaiseksi annostelemiseksi
AU6778387A (en) Needleless hypodermic injection device
WO1987003480A3 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
GB8822147D0 (en) Pharmaceutically active combination
DE59809520D1 (de) Implantierbares Doppel-Portsystem
GR3026105T3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
AU7071487A (en) Chlorpheniramine therapy
NO933235D0 (no) Anvendelse av en inhibitor for fremstilling av et medikament
GB8718721D0 (en) Optical intravenous injection monitor
EP0293241A3 (en) Intravenous pump with disposable chamber
EP0369997A3 (en) An intravenous administration infusor
AU6089086A (en) Treatment of chronic inflammatory disease
ZA913920B (en) Therapeutic compound
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.
AU612267B2 (en) Medicaments
ES279057U (es) Jeringuilla para inyecciones
GR3006805T3 (OSRAM)
SE8703788D0 (sv) Improvements in or relating to organic compounds
ZA847546B (en) Needleless hypodermic injector
BG52066B2 (en) Antitumour preparation
ZA888767B (en) Hypodermic needle